Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Taxes × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9 Neoplasm Metastasis 7 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Lung Neoplasms 5 Fallopian Tube Neoplasms 5 Endometrial Neoplasms 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma 2 Breast Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1 Rectal Neoplasms 1 Non-Small Cell Lung Cancer Metastatic 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Locally Advanced Cervical Adenocarcinoma 1 Gastric Adenocarcinoma 1

Interventions

trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 dabrafenib 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Pemetrexed 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Immunotherapy 1 Gemcitabine 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Busulfan 1 Bone Marrow Transplantation 1 Biopsy 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡